KilgourMD has raised Series A funding, led by Prelude Growth Partners, to fuel its advancements in scalp health and hair regrowth treatments. This investment also saw participation from Willow Growth, Joyance Partners, and Able Partners.
Launched in 2023, the dermatologist-founded brand has seen significant success with its clinically tested scalp serum system. Reports indicate one bottle sells every 20 seconds. Clinical data shows 95% of users experienced reduced hair shedding within six weeks of use.
The new capital will support the expansion of KilgourMD's unique ingredient portfolio, the development of new product formulations, and further clinical trials. A key focus will be on developing solutions for underserved demographics, including menopausal women.
This funding highlights the increasing market focus on scalp health as a primary driver of hair loss solutions. It signals a growing demand for scientifically validated, results-driven products in this sector.
